479 related articles for article (PubMed ID: 26091251)
1. Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer.
Ji R; Zhang B; Zhang X; Xue J; Yuan X; Yan Y; Wang M; Zhu W; Qian H; Xu W
Cell Cycle; 2015 Aug; 14(15):2473-83. PubMed ID: 26091251
[TBL] [Abstract][Full Text] [Related]
2. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Chappell WH; Abrams SL; Wong EW; Chang F; Lehmann B; Terrian DM; Milella M; Tafuri A; Stivala F; Libra M; Basecke J; Evangelisti C; Martelli AM; Franklin RA
Biochim Biophys Acta; 2007 Aug; 1773(8):1263-84. PubMed ID: 17126425
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow-derived mesenchymal stem cells increase drug resistance in CD133-expressing gastric cancer cells by regulating the PI3K/AKT pathway.
Ji N; Yu JW; Ni XC; Wu JG; Wang SL; Jiang BJ
Tumour Biol; 2016 Nov; 37(11):14637-14651. PubMed ID: 27619680
[TBL] [Abstract][Full Text] [Related]
4. The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapy.
Abrams SL; Steelman LS; Shelton JG; Wong EW; Chappell WH; Bäsecke J; Stivala F; Donia M; Nicoletti F; Libra M; Martelli AM; McCubrey JA
Cell Cycle; 2010 May; 9(9):1781-91. PubMed ID: 20436278
[TBL] [Abstract][Full Text] [Related]
5. Role of RAF/MEK/ERK pathway, p-STAT-3 and Mcl-1 in sorafenib activity in human pancreatic cancer cell lines.
Ulivi P; Arienti C; Amadori D; Fabbri F; Carloni S; Tesei A; Vannini I; Silvestrini R; Zoli W
J Cell Physiol; 2009 Jul; 220(1):214-21. PubMed ID: 19288493
[TBL] [Abstract][Full Text] [Related]
6. Exosomal transfer of tumor-associated macrophage-derived miR-21 confers cisplatin resistance in gastric cancer cells.
Zheng P; Chen L; Yuan X; Luo Q; Liu Y; Xie G; Ma Y; Shen L
J Exp Clin Cancer Res; 2017 Apr; 36(1):53. PubMed ID: 28407783
[TBL] [Abstract][Full Text] [Related]
7. Resistance to mitogen-activated protein kinase kinase (MEK) inhibitors correlates with up-regulation of the MEK/extracellular signal-regulated kinase pathway in hepatocellular carcinoma cells.
Yip-Schneider MT; Klein PJ; Wentz SC; Zeni A; Menze A; Schmidt CM
J Pharmacol Exp Ther; 2009 Jun; 329(3):1063-70. PubMed ID: 19258520
[TBL] [Abstract][Full Text] [Related]
8. Targeting the RAF/MEK/ERK, PI3K/AKT and p53 pathways in hematopoietic drug resistance.
McCubrey JA; Steelman LS; Franklin RA; Abrams SL; Chappell WH; Wong EW; Lehmann BD; Terrian DM; Basecke J; Stivala F; Libra M; Evangelisti C; Martelli AM
Adv Enzyme Regul; 2007; 47():64-103. PubMed ID: 17382374
[No Abstract] [Full Text] [Related]
9. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
10. Activation of Akt and ERK signalling pathways induced by etoposide confer chemoresistance in gastric cancer cells.
Liu SQ; Yu JP; Yu HG; Lv P; Chen HL
Dig Liver Dis; 2006 May; 38(5):310-8. PubMed ID: 16527552
[TBL] [Abstract][Full Text] [Related]
11. CD97 promotes gastric cancer cell proliferation and invasion through exosome-mediated MAPK signaling pathway.
Li C; Liu DR; Li GG; Wang HH; Li XW; Zhang W; Wu YL; Chen L
World J Gastroenterol; 2015 May; 21(20):6215-28. PubMed ID: 26034356
[TBL] [Abstract][Full Text] [Related]
12. Roles of the RAF/MEK/ERK and PI3K/PTEN/AKT pathways in malignant transformation and drug resistance.
McCubrey JA; Steelman LS; Abrams SL; Lee JT; Chang F; Bertrand FE; Navolanic PM; Terrian DM; Franklin RA; D'Assoro AB; Salisbury JL; Mazzarino MC; Stivala F; Libra M
Adv Enzyme Regul; 2006; 46():249-79. PubMed ID: 16854453
[TBL] [Abstract][Full Text] [Related]
13. KAP1 inhibits the Raf-MEK-ERK pathway to promote tumorigenesis in A549 lung cancer cells.
Wu GJ; Pen J; Huang Y; An S; Liu Y; Yang Y; Hao Q; Guo XX; Xu TR
Mol Carcinog; 2018 Oct; 57(10):1396-1407. PubMed ID: 29917268
[TBL] [Abstract][Full Text] [Related]
14. MSC-regulated lncRNA MACC1-AS1 promotes stemness and chemoresistance through fatty acid oxidation in gastric cancer.
He W; Liang B; Wang C; Li S; Zhao Y; Huang Q; Liu Z; Yao Z; Wu Q; Liao W; Zhang S; Liu Y; Xiang Y; Liu J; Shi M
Oncogene; 2019 Jun; 38(23):4637-4654. PubMed ID: 30742067
[TBL] [Abstract][Full Text] [Related]
15. Expression of orphan nuclear receptor NR4A2 in gastric cancer cells confers chemoresistance and predicts an unfavorable postoperative survival of gastric cancer patients with chemotherapy.
Han Y; Cai H; Ma L; Ding Y; Tan X; Chang W; Guan W; Liu Y; Shen Q; Yu Y; Zhang H; Cao G
Cancer; 2013 Oct; 119(19):3436-45. PubMed ID: 23821160
[TBL] [Abstract][Full Text] [Related]
16. PAK4 confers cisplatin resistance in gastric cancer cells via PI3K/Akt- and MEK/ERK-dependent pathways.
Fu X; Feng J; Zeng D; Ding Y; Yu C; Yang B
Biosci Rep; 2014 Apr; 34(2):. PubMed ID: 27919028
[TBL] [Abstract][Full Text] [Related]
17. Exosomes secreted by mesenchymal stromal/stem cell-derived adipocytes promote breast cancer cell growth via activation of Hippo signaling pathway.
Wang S; Su X; Xu M; Xiao X; Li X; Li H; Keating A; Zhao RC
Stem Cell Res Ther; 2019 Apr; 10(1):117. PubMed ID: 30971292
[TBL] [Abstract][Full Text] [Related]
18. Exosomes derived from mesenchymal stem cells inhibit mitochondrial dysfunction-induced apoptosis of chondrocytes via p38, ERK, and Akt pathways.
Qi H; Liu DP; Xiao DW; Tian DC; Su YW; Jin SF
In Vitro Cell Dev Biol Anim; 2019 Mar; 55(3):203-210. PubMed ID: 30783864
[TBL] [Abstract][Full Text] [Related]
19. Involvement of p53 and Raf/MEK/ERK pathways in hematopoietic drug resistance.
McCubrey JA; Abrams SL; Ligresti G; Misaghian N; Wong EW; Steelman LS; Bäsecke J; Troppmair J; Libra M; Nicoletti F; Molton S; McMahon M; Evangelisti C; Martelli AM
Leukemia; 2008 Nov; 22(11):2080-90. PubMed ID: 18685611
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib inhibits 5-fluorouracil-resistant gastric cancer cell growth.
Kim HM; Kim SA; Park SB; Cho JH; Song SY
Scand J Gastroenterol; 2017 May; 52(5):577-584. PubMed ID: 28110575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
